Iqgen-X Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
- Paid Up Capital ₹ 1.13 Cr
- Company Age 8 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.28 Cr
- Revenue Growth -13.64%
- Profit Growth 86.35%
- Ebitda 373.39%
- Net Worth 5.17%
- Total Assets -3.00%
About Iqgen-X Pharma
Iqgen-X Pharma Private Limited (IPPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 13 October 2016 (Eight years and seven months 0 days old ). Its registered office is in Navi Mumbai, Maharashtra.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.13 Cr.
The company currently has active open charges totaling ₹2.28 Cr.
Parizad Elchidana, Karan Singh, Madhu Hariharan, and Three other members serve as directors at the Company.
Company Details
- Location Navi Mumbai, Maharashtra
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74999MH2016PTC286716
- Company No.
286716
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Oct 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Pharma
Iqgen-X Pharma Private Limited
Explore comprehensive data for Iqgen-X Pharma Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Iqgen-X Pharma?
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Parizad Elchidana  | Additional Director | 30-Sep-2021 | Current |
Karan Singh  | Additional Director | 16-Oct-2020 | Current |
Madhu Hariharan  | Director | 01-Apr-2017 | Current |
| Yatendra Kumar | Director | 01-Apr-2017 | Current |
| Mandar Kodgule | Director | 01-Apr-2017 | Current |
| Yogita Kodgule | Director | 01-Apr-2017 | Current |
Financial Performance of Iqgen-X Pharma.
Iqgen-X Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 13.64% decrease. The company also saw a substantial improvement in profitability, with a 86.35% increase in profit. The company's net worth moved up by a moderate rise of 5.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Iqgen-X Pharma?
In 2023, Iqgen-X Pharma had a promoter holding of 40.80% and a public holding of 59.20%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Acg Cares FoundationKaran Singh is a mutual person
Acg Associated Capsules Private LimitedKaran Singh is a mutual person
- Acg Pam Pharma Technologies Private Limited
Karan Singh is a mutual person
- Acg Cellulose Private Limited
Karan Singh is a mutual person
- Acg Pharmapack Private Limited
Karan Singh is a mutual person
- Acg Inspection Systems Private Limited
Karan Singh is a mutual person
Charges (Loans)
Open Charges
₹2.28 Cr
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Canara Bank : 2.28 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Jul 2020 | Canara Bank | ₹2.80 M | Open |
| 25 Sep 2017 | Canara Bank | ₹2.00 Cr | Open |
How Many Employees Work at Iqgen-X Pharma?
Iqgen-X Pharma has a workforce of 34 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Iqgen-X Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Iqgen-X Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Iqgen-X Pharma
Recent activity within the organization
- Annual General Meeting
Iqgen-X Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
- Balance Sheet
Iqgen-X Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.
- Director Appointment
Karan Jasjit Singh was appointed as a Additional Director was appointed as a Additional Director on 16 Oct 2020 & has been associated with this company since 4 years 6 months .
- Charges
A charge with Canara Bank of Rs. 2.00 Cr registered on 25 Sep 2017 with Charge ID 100135679 was modified on 29 Aug 2020.
- Charges
A charge with Canara Bank amounted to Rs. 0.28 Cr with Charge ID 100355277 was registered on 28 Jul 2020.
- Charges
A charge with Canara Bank amounted to Rs. 2.00 Cr with Charge ID 100135679 was registered on 25 Sep 2017.
Recent News, Updates & Announcement
Frequently asked questions
What is the Incorporation or founding date of Iqgen-X Pharma Private Limited?
Iqgen-X Pharma Private Limited was incorporated on 13 Oct 2016.
What is authorized share capital and paid-up capital of Iqgen-X Pharma Private Limited?
The authorized share capital of Iqgen-X Pharma Private Limited is ₹ 2.00 Cr and paid-up capital is ₹ 1.13 Cr.
Who are the current board members & directors of Iqgen-X Pharma Private Limited?
Currently 6 directors are associated with Iqgen-X Pharma Private Limited.
- Parizad Adil Elchidana
- Karan Jasjit Singh
- Madhu Hariharan
- Yatendra Kumar
- Mandar Madhukar Kodgule
- Yogita Mandar Kodgule
What is the registered address of Iqgen-X Pharma Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Iqgen-X Pharma Private Limited is A-165 Ttc Industrial Area, Khairane. India, Navi Mumbai, Maharashtra, 400705.
What is the corporate identification number (CIN) and company number of Iqgen-X Pharma Private Limited?
The corporate identification number (CIN) of Iqgen-X Pharma Private Limited is U74999MH2016PTC286716 and the company number is 286716 as per Ministry of Corporate Affairs (MCA).
What is the official website of Iqgen-X Pharma Private Limited?
The Official website of Iqgen-X Pharma Private Limited is https://www.iqgenx.com
What has been the recent revenue trend for Iqgen-X Pharma Private Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Iqgen-X Pharma Private Limited has fallen by -13.64%.
How many employees does Iqgen-X Pharma Private Limited currently have?
As Per 2023 financial reports, 34 employees are currently employed by Iqgen-X Pharma Private Limited.
What change has been observed in the net worth of Iqgen-X Pharma Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Iqgen-X Pharma Private Limited has experienced an upsurge of 5.17%.
What are the total open charges for Iqgen-X Pharma Private Limited?
As per the financial statements for fiscal Year 2023, The total open charges for Iqgen-X Pharma Private Limited amount to ₹ 2.28 Cr.
When was the last Balance Sheet of Iqgen-X Pharma Private Limited filed with the ROC?
The most recent Balance Sheet for Iqgen-X Pharma Private Limited was filed with the ROC on 31 Mar 2023.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
MV
Mousumi VemulaDirectorUV
Urmila VemulaDirectorPN
Prabhakaran NairAdditional Director
Similar Companies Based on Drug Formulation & Development
Mylan Laboratories Limited Hyderabad, Telangana, India
Sun Pharma Laboratories Limited Vadodara, Gujarat, India
Sun Pharmaceutical Industries Limited Vadodara, Gujarat, India
Lupin Limited Mumbai, Maharashtra, India
Alkem Laboratories Limited Mumbai, Maharashtra, India
Hetero Labs Limited Rangareddy, Telangana, India
Aurobindo Pharma Ltd Hyderabad, Telangana, India
Cipla Limited Mumbai, Maharashtra, India